In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | N/A | |
2022 | N/A | |
2021 | N/A | |
2020 | N/A | |
2019 | N/A | -100% |
2018 | $2.03 M | 87.83% |
2017 | $1.08 M | 132.33% |
2016 | $0.46 M | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Evoke Pharma
EVOK | $5.18 M | N/A | ๐บ๐ธ USA |
Endo International
ENDPQ | $2.01 B | N/A | ๐ฎ๐ช Ireland |
Aerie Pharmaceuticals AERI | $0.21 B | N/A | ๐บ๐ธ USA |
Catalent CTLT | $4.09 B | N/A | ๐บ๐ธ USA |